BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 9361329)

  • 21. Selective attenuation of the antinociceptive effects of mu opioids by the putative dopamine D3 agonist 7-OH-DPAT.
    Cook CD; Rodefer JS; Picker MJ
    Psychopharmacology (Berl); 1999 Jun; 144(3):239-47. PubMed ID: 10435390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
    Rosenzweig-Lipson S; Bergman J
    J Pharmacol Exp Ther; 1993 Nov; 267(2):765-75. PubMed ID: 7902432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of putative dopamine D3 receptor agonists, 7-OH-DPAT, and quinpirole, on yawning, stereotypy, and body temperature in rats.
    Kurashima M; Yamada K; Nagashima M; Shirakawa K; Furukawa T
    Pharmacol Biochem Behav; 1995 Nov; 52(3):503-8. PubMed ID: 8545466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the discriminative-stimulus effects of SKF 38393 with those of other dopamine receptor agonists.
    Desai RI; Terry P; Katz JL
    Behav Pharmacol; 2003 May; 14(3):223-8. PubMed ID: 12799524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The discriminative stimulus effects of dopamine D2- and D3-preferring agonists in rats.
    Koffarnus MN; Greedy B; Husbands SM; Grundt P; Newman AH; Woods JH
    Psychopharmacology (Berl); 2009 Apr; 203(2):317-27. PubMed ID: 18807248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biphasic effects of 7-OH-DPAT on the acquisition of responding for conditioned reward in rats.
    Sutton MA; Rolfe NG; Beninger RJ
    Pharmacol Biochem Behav; 2001; 69(1-2):195-200. PubMed ID: 11420086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 7-OH-DPAT effects on latent inhibition: low dose facilitation but high dose blockade: implications for dopamine receptor involvement in attentional processes.
    Chagas-Martinich L; Carey RJ; Carrera MP
    Pharmacol Biochem Behav; 2007 Mar; 86(3):441-8. PubMed ID: 17291574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased locomotor activity after microinjection of dopamine D2/D3 receptor agonists and antagonists into lobule 9/10 of the cerebellum: a D3 receptor mediated effect?
    Boulay D; Depoortere R; Perrault G; Sanger DJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Jan; 24(1):39-49. PubMed ID: 10659982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential ability of D1 and D2 dopamine receptor agonists to induce and modulate expression and reinstatement of cocaine place preference in rats.
    Graham DL; Hoppenot R; Hendryx A; Self DW
    Psychopharmacology (Berl); 2007 Apr; 191(3):719-30. PubMed ID: 16835769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Respective roles of dopamine D2 and D3 receptors in food-seeking behaviour in rats.
    Duarte C; Biala G; Le Bihan C; Hamon M; Thiébot MH
    Psychopharmacology (Berl); 2003 Feb; 166(1):19-32. PubMed ID: 12525958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine D1/D2 agonists injected into nucleus accumbens and ventral pallidum differentially affect locomotor activity depending on site.
    Gong W; Neill DB; Lynn M; Justice JB
    Neuroscience; 1999; 93(4):1349-58. PubMed ID: 10501459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation rearing-induced facilitation of Pavlovian learning: abolition by postsession intra-amygdala nafadotride.
    Phillips GD; Harmer CJ; Hitchcott PK
    Physiol Behav; 2002 Aug; 76(4-5):677-84. PubMed ID: 12127008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of the discriminative stimulus effects of mu opioid agonists in rats: II. Effects of dopamine D2/3 agonists.
    Cook CD; Beardsley PM
    Behav Pharmacol; 2004 Feb; 15(1):75-83. PubMed ID: 15075629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced dopamine efflux in the amygdala by a predictive, but not a non-predictive, stimulus: facilitation by prior repeated D-amphetamine.
    Harmer CJ; Phillips GD
    Neuroscience; 1999 Apr; 90(1):119-30. PubMed ID: 10188939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discriminative stimulus effects of apomorphine and 7-OH-DPAT: a potential role for dopamine D3 receptors.
    Sanger DJ; Depoortere R; Perrault G
    Psychopharmacology (Berl); 1997 Apr; 130(4):387-95. PubMed ID: 9160856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of D2 and D3 receptor-selective ligands in rats trained to discriminate cocaine from saline.
    Garner KJ; Baker LE
    Pharmacol Biochem Behav; 1999 Oct; 64(2):373-8. PubMed ID: 10515316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altering D1 receptor activity in the basolateral amygdala impairs fear suppression during a safety cue.
    Ng KH; Pollock MW; Urbanczyk PJ; Sangha S
    Neurobiol Learn Mem; 2018 Jan; 147():26-34. PubMed ID: 29175512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of dopamine receptors in the ventral tegmental area in conditioned fear.
    de Oliveira AR; Reimer AE; Brandão ML
    Behav Brain Res; 2009 May; 199(2):271-7. PubMed ID: 19111792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Motor actions of 7-OH-DPAT in normal and reserpine-treated mice suggest involvement of both dopamine D2 and D3 receptors.
    Starr MS; Starr BS
    Eur J Pharmacol; 1995 Apr; 277(2-3):151-8. PubMed ID: 7493603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of the mesoamygdala dopaminergic pathway impairs the retrieval of conditioned fear associations.
    Nader K; LeDoux JE
    Behav Neurosci; 1999 Oct; 113(5):891-901. PubMed ID: 10571473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.